Savient Pharmaceuticals (SVNT) Tops Q1 Per Share Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts SVNT Hot Sheet
Price: $40.05 --0%
Financial Fact:
Other (expense) income, net: 240K
Today's EPS Names:
PKE, BYRN, HELE, More
Financial Fact:
Other (expense) income, net: 240K
Today's EPS Names:
PKE, BYRN, HELE, More
Join SI Premium – FREE
Savient Pharmaceuticals (NASDAQ: SVNT) reported Q1 loss of ($0.19), $0.12 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $1.29 million versus the consensus estimate of $2.09 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Helen of Troy (HELE) Tops Q2 EPS by 28c, Misses on Revenue; Offers FY27 Guidance
- Lamb Weston (LW) Tops Q1 EPS by 15c ; Offers Guidance
- Applied Digital (APLD) Tops Q1 EPS by 26c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
